Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | -5.07% | -3.86% | -28.55% |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
04-30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.55% | 35.03M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+36.47% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Insider Trends: Marker Therapeutics Insider 90-Day Buying Trend Added to with Purchase